BMJ  2004;328:179-180 (24 January), doi:10.1136/bmj.328.7433.179

Editorial

Treatment of acute pyelonephritis in children

Evidence favours the oral route and a short course of appropriate antibiotics

The first 150 words of the full text of this article appear below.

A 9 month old girl presents with high fever, vomiting, lethargy, and bacteriologically confirmed urinary tract infection. The diagnosis is clear—acute pyelonephritis. This is a common problem and the cause of about 5% of febrile episodes in children.1 But how should she be treated? Which antibiotics should be given and by which route? For how long should antibiotics be given? This article summarises what we know about treatment of acute pyelonephritis from randomised trials and what we think we know about treatment, based on clinical experience.

Acute pyelonephritis comprises urinary tract infection with systemic features including fever, vomiting, abdominal or loin pain, and lethargy. Fever is the most useful symptom clinically. Compared with the reference standard for pyelonephritis—technetium-99m dimercaptosuccinic acid scanning—fever is very sensitive but has only moderate specificity. In few afebrile children—except very young infants—the renal parenchyma is affected. Conversely in about 50% of children with clinical pyelonephritis the . . . [Full text of this article]

Jonathan C Craig, consultant paediatric nephrologist

(jonc@health.usyd.edu.au), Centre for Kidney Research, Children's Hospital at Westmead, Sydney, NSW 2145 Australia

Elisabeth M Hodson, head

department of nephrology, Centre for Kidney Research, Children's Hospital at Westmead, Sydney, NSW 2145 Australia


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial
Giovanni Montini, Antonella Toffolo, Pietro Zucchetta, Roberto Dall'Amico, Daniela Gobber, Alessandro Calderan, Francesca Maschio, Luigi Pavanello, Pier Paolo Molinari, Dante Scorrano, Sergio Zanchetta, Walburga Cassar, Paolo Brisotto, Andrea Corsini, Stefano Sartori, Liviana Da Dalt, Luisa Murer, and Graziella Zacchello
BMJ 2007 335: 386. [Abstract] [Full Text] [PDF]

Treatment of acute pyelonephritis in children: Conclusions should have been more cautious
Juan M Lozano
BMJ 2004 328: 957. [Extract] [Full Text]

This article has been cited by other articles:

  • Montini, G., Toffolo, A., Zucchetta, P., Dall'Amico, R., Gobber, D., Calderan, A., Maschio, F., Pavanello, L., Molinari, P. P., Scorrano, D., Zanchetta, S., Cassar, W., Brisotto, P., Corsini, A., Sartori, S., Dalt, L. D., Murer, L., Zacchello, G. (2007). Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ 335: 386-386 [Abstract] [Full text]  
  • Arkutu, N., Rock, W. P. (2006). Current Products and Practice: Does mentoring have a role in orthodontic training programmes?. J. Orthod. 33: 142-146 [Abstract] [Full text]  
  • Lozano, J. M (2004). Treatment of acute pyelonephritis in children: Conclusions should have been more cautious. BMJ 328: 957-957 [Full text]  

Rapid Responses:

Read all Rapid Responses

Are oral and intravenous antibiotics for children with pyelonepritis really equivalent? Caution needed
Juan M. Lozano
bmj.com, 30 Jan 2004 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview